OSTX vs OVID

OS Therapies Incorporated vs Ovid Therapeutics Inc. — Valuation Comparison 2026

OSTX

Pharmaceutical Preparations
OS Therapies Incorporated
Quality
3.1
out of 10
Value Trap
12
SAFE
Price
$2.14
Last close
Models
6/13
Active
VS

OVID

Pharmaceutical Preparations
Ovid Therapeutics Inc.
Quality
5.3
out of 10
Value Trap
32
LOW
Price
$2.73
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType OSTX Fair ValueOSTX Upside OVID Fair ValueOVID Upside
Bayesian DCF Intrinsic $0.47 -77.9% $0.75 -72.6%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.04 -98.3% $0.83 -69.7%
PWERM Option-Based $1.95 -9.1% $2.42 -11.2%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for OSTX vs OVID — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

OSTX vs OVID — Which Stock Is More Undervalued?

OVID scores higher with a 5.3/10 quality rating vs OSTX's 3.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing OS Therapies Incorporated (OSTX) and Ovid Therapeutics Inc. (OVID) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

OSTX currently trades at $2.14 with a QOC of 3.1/10, while OVID trades at $2.73 with a QOC of 5.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).